Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism Bcr-Abl inhibitors(Bcr-Abl tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H16ClN3O |
InChIKeyDDQBLOJDYBXLSS-OBQHEISASA-N |
CAS Registry1245722-57-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Philadelphia chromosome positive chronic myelogenous leukemia | Preclinical | China | 03 Feb 2014 |





